Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664170 · ClinicalTrials.gov registry record · Phase 1
A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer
A Phase 1 study of Advanced Cancer, sponsored by Mast Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
- 13
- Study locations
NCT00664170: Completed Phase 1 study of Advanced Cancer, sponsored by Mast Therapeutics.
NCT00664170 is a Phase 1 study of Advanced Cancer that has completed, run by Mast Therapeutics. The registered enrollment target is 39 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (84% lower). The trial reports 13 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664170, a Phase 1 study of Advanced Cancer, has completed, sponsored by Mast Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to compare an injectable emulsion form of docetaxel to Taxotere in patients with advanced cancer.
Conditions Studied
Interventions
- DRUG docetaxel
- DRUG ANX-514
Study Locations (13)
Other
- Marcelo T de Alvear - Buenos Aires
- Centro Oncologico de Integracion Regional - Mendoza
- Hospital Privado Santa Clara de Asis - Salta
- Centro Medico San Roque - San Miguel de Tucumán
- Isis Centro Especializado - Santa Fe
- Tallinn Cancer Clinic - Tallinn
- Tartu University Hospital, Clinic of Hematology and Oncology - Tartu
Alabama
- Northwest Alabama Cancer Center - Muscle Shoals
California
- UCSD Moores Cancer Center - La Jolla
Ohio
- Signal Point Hematology/Oncology Inc. - Middletown
Buenos Aires
- Hospital Universitario Austral - Buenos Aires
Santa Fe Province
- Centro Oncologico de Rosario - Rosario
Tucumán Province
- Hospital Regional de Concepcion - Concepción
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
What the finished NCT00664170 record still lists
NCT00664170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which docetaxel is the first listed.
NCT00664170 lists 13 locations in 7 states (Other, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT00664170 about?
NCT00664170 is a clinical study titled "A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer". The purpose of this study is to compare an injectable emulsion form of docetaxel to Taxotere in patients with advanced cancer.
What is the current status of trial NCT00664170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2008-04. Estimated completion is 2009-04.
What conditions does trial NCT00664170 study?
This clinical trial studies the following conditions: Advanced Cancer.
What interventions are being tested in trial NCT00664170?
The interventions under investigation include: docetaxel (DRUG), ANX-514 (DRUG).
Who is sponsoring clinical trial NCT00664170?
This trial is sponsored by Mast Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00664170 being conducted?
This trial has 13 study locations across Alabama, California, Ohio, Buenos Aires, Santa Fe Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00664170's enrollment target sits among peer trials
39 92nd of 122 higher than 30 of 122 other Advanced Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
RECRUITING · Phase 1
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study in Patients With Advanced Cancers
RECRUITING · Phase 1
-
A Study of MGC026 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia